Stock Market Down To Start Earnings Week; Chinese Stocks Getting Hit | Investor's Business Daily

2022-07-15 23:22:57 By : Ms. Cathy Zhou

BREAKING:  Market Ramps Higher, Helped By Strong Earnings

The major stock market indexes are all down and have wavered in the last hour, but are holding above the lows of the day. The Nasdaq and small-cap Russell 2000 lag the other indexes.

Investors are showing concern this morning about potential reduced profits from inflation that will affect the upcoming earnings season. New Chinese restrictions from increased Covid-19 cases are adding to investors' nervousness.

At midday, the Nasdaq is down 1.9%, while the S&P 500 dropped 1%. The Dow Jones Industrial Average is down 0.4%, and the Russell 2000 is down 1.9%. NYSE volume is up 3.9% and Nasdaq volume is down 4.7% vs. the same time on Friday.

Most Trusted Financial Companies — Take A Survey And Win A $50 Amazon Gift Card

Pliant Therapeutics (PLRX) is up 113.8% on very heavy volume triggering a circuit breaker temporarily halting trading earlier this morning. The company announced positive data from a phase 2a clinical trial for its experimental idiopathic pulmonary fibrosis treatment. RBC Capital Markets raised its price target to 54 from 35.

Cross Country Healthcare (CCRN), a health care staffing service, is up 4.9% on heavy volume. The company was added to the IBD 50 last Friday. Cross Country Healthcare had strong quarterly earnings-per-share growth of 193% in March, 637% in December and 194% in September. Quarterly sales have also been impressive, with a 140% gain in March, a 197% increase in December and a 93% rise in September. CCRN has some solid fundamentals including a 98 EPS Rating and a 97 Composite Rating.

Cross Country Healthcare stock broke above the 200-day moving average on Friday on the MarketSmith chart.

Merck (MRK) is up 1.6% as the health care group remains strong. The stock rose above the 5% buy zone on the MarketSmith chart.

Murphy USA (MUSA), a gas station and mini-market company, is seeing another strong day, up 3%, trying to break out past the 262.68 buy point, coming out of a sideways base.

Alibaba (BABA) is down 8.4% as China's Covid-19 cases surge, and is now below the 21-day exponential moving average. Electric vehicle maker NIO (NIO) lost 7.8% and Li Auto (LI) is off 3%.

The iShares Trust China Large-Cap ETF (FXI) is seeing weakness, down 4.1%.

Broadcom (AVGO), a microchip giant, is down 3.2% on news of its president Thomas Krause, leaving the company for another job on July 15.

Invesco QQQ Trust (QQQ), an ETF corresponding to the Nasdaq 100 Index, is down 2% and dropped below the 21-day exponential moving average.

Crude oil futures are down 0.9%, with crude oil at $103.87 per barrel. The SPDR S&P Energy ETF (XLE) is down 1.4%.

Bitcoin futures are down 6.4% today to $20,370 and trading near the lows of the day.

The Innovator IBD 50 ETF (FFTY), a gauge of growth stocks, is down 1.2%, in line with major indexes.

Get Free IBD Newsletters: Market Prep | Tech Report | How To Invest

What Is CAN SLIM? If You Want To Find Winning Stocks, Better Know It

IBD Live: Learn And Analyze Growth Stocks With The Pros

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Market Rally Hits China Wall; Tesla, Twitter Tumble

10:18 AM ET Here are July's best Chinese stocks to buy and watch. Hopes for new stimulus and EV subsidies have helped Chinese...

10:18 AM ET Here are July's best Chinese stocks to buy and watch....

Low-code software tools make it easier for nontechnical business people to create apps, speeding up the digital transformation of companies. (© Chris Gash)

Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!

Get market updates, educational videos, webinars, and stock analysis.

Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.

Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.

*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.

Ownership data provided by Refinitiv and Estimates data provided by FactSet.

© 2000-2022 Investor's Business Daily, LLC. All rights reserved

top.scrollTo(duration=200)" class="scrollToTop">Top